Scilex, a Sorrento Company, Highlights Safety Data From Phase 1 Trial of SP-104, a Proprietary Low Dose Naltrexone for Fibromyalgia

GuruFocus
20 June 2022
https://www.gurufocus.com/news/1770836/scilex-a-sorrento-company-highlights-safety-data-from-phase-1-trial-of-sp104-a-proprietary-low-dose-naltrexone-for-fibromyalgia

Liz - Scotland: Multiple Sclerosis (MS) (LDN; low dose naltrexone)

LDN Webinar Presentation 18 May 2022: Dr Masoud Rashidi - LDN, Dosing, Fillers and Compounded Options. LDN, ULDN and Pain/Opioid Issues

Sponsored by Innovative Compounding Pharmacy https://icpfolsom.com/

LDN Webinar Presentation 18 May 2022: Dr Mathewson - LDN as supportive care for Oncology and Autoimmune patients: Case Reviews

Sponsored by Innovative Compounding Pharmacy https://icpfolsom.com/

LDN Webinar Presentation 18 May 2022: Dr Sato-Re - How and why I prescribe LDN in my integrative and general practice

Sponsored by Innovative Compounding Pharmacy https://icpfolsom.com/

LDN Webinar 18 May 2022 (LDN; low dose naltrexone)

LDN Questions Answered Live by

Pharmacist Dr Masoud Rashidi - LDN Specialist
Dr Sato-Re
Dr Mathewson

Sponsored by Innovative Compounding Pharmacy icpfolsom.com

Naltrekson ograniczył ból związany z zespołem piekących ust
(Naltrexone reduced the pain associated with burning mouth syndrome)

Dentonet Doctor
10 May 2022
https://dentonet.pl/naltrekson-ograniczyl-bol-zwiazany-z-zespolem-piekacych-ust/

Low-Dose Naltrexone Holds Promise for Relief of Phantom Limb Pain

Amplitude
04 May 2022
https://livingwithamplitude.com/low-dose-naltrexone-treatment-for-phantom-limb-pain-ldn/

A growing body of research has shown that very small doses of naltrexone—less than a tenth of the amount used to treat substance abuse—can alleviate phantom limb pain and other forms of chronic pain without the unwanted side effects.